Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential impact of the 4CMenB vaccine on oropharyngeal carriage of Neisseria meningitidis.

The Journal of infection - 1 Dec 2017

Abad Raquel, Medina Verónica, Fariñas Maria Del Carmen, Martínez-Martínez Luis, Bambini Stefania, Dari A, Medini Duccio, Pizza Mariagrazia, Vázquez Julio A

Abstract excerpt

The analysis of the potential impact of the meningococcal vaccines in asymptomatic carriers has become one of the key aspects in the evaluation of new vaccines and of their impact on disease control. An important step in this direction is provided by the analysis of the sequence variability and surface-exposure of the 4CMenB (Bexsero®) vaccine antigens, as well as the cross-reactivity of vaccine induced...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, Bacterial
Share to Carrier State

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross Reactions

Share to Meningococcal Infections

Share to Meningococcal Vaccines

Share to Neisseria meningitidis

Share to Oropharynx

Share to Serogroup

Source

Identifiers

PMID: 28987549
DOI: 10.1016/j.jinf.2017.09.021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential impact of the 4CMenB vaccine on oropharyngeal carriage of Neisseria meningitidis.PMID 28987549Read ↗

Molecular and serological diversity of Neisseria meningitidis carrier strains isolated from Italian students aged 14 to 22 years.Semantic proximity Read ↗

Progressive Decrease in the Potential Usefulness of Meningococcal Serogroup B Vaccine (4CMenB, Bexsero®) in Gipuzkoa, Northern SpainSemantic proximity Read ↗

Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 Neisseria meningitidis isolates causing invasive meningococcal disease in Argentina in 2010-2014.Semantic proximity Read ↗

Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in ItalySemantic proximity Read ↗

Bioinformatics Analysis of Global Diversity in Meningococcal Vaccine Antigens over the Past 10 Years; Vaccine Efficiency PrognosisSemantic proximity Read ↗

Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010–2016Semantic proximity Read ↗

Looking beyond meningococcal B with the 4CMenB vaccine: the Neisseria effectSemantic proximity Read ↗

Genetic characteristics of Neisseria meningitidis serogroup B strains carried by adolescents living in Milan, Italy: implications for vaccine efficacy.Semantic proximity Read ↗

Predicted Strain Coverage of a New Meningococcal Multicomponent Vaccine (4CMenB) in Spain: Analysis of the Differences with Other European CountriesSemantic proximity Read ↗

A large portion of meningococcal antigen typing system-negative meningococcal strains from spain is killed by sera from adolescents and infants immunized with 4CMenB.Semantic proximity Read ↗

Unveiling New Aspects of Meningococcal Carriage and Disease Prevention.Semantic proximity Read ↗

Novel meningococcal 4CMenB vaccine antigens - prevalence and polymorphisms of the encoding genes in Neisseria gonorrhoeae.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.